| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma. | Arch Otolaryngol Head Neck Surg | 2010 | 1.52 |
| 2 | Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo model. | Anticancer Drugs | 2010 | 0.91 |
| 3 | Robot-assisted surgery for upper aerodigestive tract neoplasms. | Arch Otolaryngol Head Neck Surg | 2009 | 0.90 |
| 4 | Management of the N0 neck in recurrent laryngeal squamous cell carcinoma. | Laryngoscope | 2010 | 0.88 |
| 5 | Assessment of tissue autofluorescence and reflectance for oral cavity cancer screening. | Otolaryngol Head Neck Surg | 2011 | 0.87 |
| 6 | Assessment of erlotinib as adjuvant chemoprevention in high-risk head and neck cancer patients. | Ann Surg Oncol | 2014 | 0.83 |
| 7 | Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma. | Int J Radiat Oncol Biol Phys | 2012 | 0.78 |